•  
  •  

News Releases

SenesTech to Present ContraPest® at the Pest Control Operators of California Conference June 20-22

FLAGSTAFF, Ariz., May 29, 2018 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced that the Company will be presenting ContraPest® at the Pest Control Operators Of California (PCOC) conference, held June 20-22 in South Lake Tahoe at the Harrah's Resort and Casino. SenesTech will be in Booth 44.

SenesTech Logo

"The PCOC has a unique history amongst trade associations. The origins of the PCOC are a grass roots effort to force the industry to adopt stringent standards of professionalism in an industry and at a time when there were few standards. To this day, a central tenet of their code of ethics is 'to render pest control service in a safe and efficient manner with due consideration for its possible effects on the environment.' This makes the PCOC conference an ideal place to introduce ContraPest to the California market," said Dr. Loretta P. Mayer, co-Founder and CEO of SenesTech.

 "At the PCOC, we will have immediate access to every major pest manager in California, and every distributor servicing California. I expect this conference to be extremely productive," said Joe Malinowski, VP of Sales for SenesTech. "The timing may work out such that we can begin shipping product to our initial customers and stocking orders that same week."

About SenesTech
SenesTech is changing the paradigm of pest management by targeting the root cause of the problem: reproduction.

ContraPest® is an innovative technology that targets the reproductive capabilities of Norway and roof rats. As a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down. Our delivery system is designed to minimize handler exposure, and ContraPest is dispensed inside tamper resistant bait stations, minimizing the risks to non-target species.

As a versatile tool, ContraPest can be used within Integrated Pest Management (IPM) programs to help reduce reproduction and magnify the success of IPM protocols or as a standalone, non-lethal solution for customers that are looking to reduce or eliminate the use of lethal methodologies.

ContraPest is a Restricted Use Pesticide, due to applicator expertise. Please read and comply with all label instructions. For more information visit the SenesTech website at www.senestech.com.

Safe Harbor Statement
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" involve estimates, assumptions, risks and uncertainties and describe future expectations, plans, results, or strategies. Forward looking statements are generally preceded by words such as "may," "future," "believe," "plan," "will" or "should," "continue," "expect," "anticipates," "eventually," "projected" or other comparable terminology. Such forward looking statements include, but are not limited to: our expectations regarding our utilization of operating cash, our expectations regarding operating results, and our expectations related to our product messaging and distribution relationships. You should not unduly rely on forward looking statements because such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in our filings with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

 

SOURCE SenesTech, Inc.

For further information: Investor: Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700, senestech@lythampartners.com; or Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143

print email pdf